Banding ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children

  • Protocol
  • Intervention

Authors

  • Juan Cristóbal Gana,

    Corresponding author
    1. Division of Paediatrics, Escuela de Medicina, Pontificia Universidad Católica de Chile, Gastroenterology, Hepatology, and Nutrition Unit, Santiago, Region Metropolitana, Chile
    • Juan Cristóbal Gana, Gastroenterology, Hepatology, and Nutrition Unit, Division of Paediatrics, Escuela de Medicina, Pontificia Universidad Católica de Chile, 85 Lira, Santiago, Region Metropolitana, 8330074, Chile. jcgana@gmail.com.

    Search for more papers by this author
  • Lorena I Cifuentes,

    1. Escuela de Medicina, Pontificia Universidad Católica de Chile, Division of Paediatrics, Evidence-based Health Care Programme, Santiago, Metroplitana, Chile
    Search for more papers by this author
  • Jaime Cerda,

    1. Faculty of Medicine, Pontificia Universidad Católica de Chile, Department of Public Health, Santiago, Chile
    Search for more papers by this author
  • Luis A Villarroel del Pino,

    1. Faculty of Medicine, Pontificia Universidad Católica de Chile, Department of Public Health, Santiago, Chile
    Search for more papers by this author
  • Alfredo Peña,

    1. Escuela de Medicina, Pontificia Universidad Católica de Chile, Department of Paediatrics, Division of Paediatrics, Santiago, Chile
    Search for more papers by this author
  • Marcela Rivera Cornejo

    1. Pontificia Universidad Católica de Chile, Biblioteca Biomedica, Sistema de Bibliotecas, Santiago, Región Metropolitana, Chile
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the benefits and harms of banding ligation compared to any type of beta-blocker for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.